Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Desmeules

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Revue Medicale Suisse|August 6, 2011
[Opioid rotation: from theory to practice. Interdisciplinary recommendations from the Geneva University Hospitals pain network]L Roulet, C Luthy, N Garin, et al.
The Pharmacogenomics Journal|July 2, 2008
The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype predictionM C Rebsamen, J Desmeules, Y Daali, et al.
Journal of Viral Hepatitis|July 6, 2012
Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infectionF Girardin, Y Daali, M Gex-Fabry, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Revue Medicale Suisse|August 6, 2011
[Opioid rotation: from theory to practice. Interdisciplinary recommendations from the Geneva University Hospitals pain network]L Roulet, C Luthy, N Garin, et al.
The Pharmacogenomics Journal|July 2, 2008
The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype predictionM C Rebsamen, J Desmeules, Y Daali, et al.
Journal of Viral Hepatitis|July 6, 2012
Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infectionF Girardin, Y Daali, M Gex-Fabry, et al.
Pageof 6